Overview

A Study to Evaluate the Pharmacokinetics (Drug Levels and Metabolism), Safety, and Tolerability of BMS-986259 in Participants With Various Levels of Kidney Function

Status:
Completed

Trial end date:
2021-07-16

Target enrollment:

Participant gender:

Summary

A study to evaluate the drug effect, safety, and tolerability of BMS-986259 in participants with different levels of kidney function

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb